Get 20% lifetime commission for referring investors to digrin.com
here.
Rezolute, Inc. (RZLT) Financials
RZLT Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 112.8 million | 12.2 million |
| March 31, 2026 | 125.5 million | 8.6 million |
| Dec. 31, 2025 | 138.6 million | 10.6 million |
| Sept. 30, 2025 | 158.7 million | 11.5 million |
RZLT Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -13.1 million | ? |
| March 31, 2026 | -13.7 million | 4.4 million |
| Dec. 31, 2025 | -20.3 million | 3.4 million |
| Sept. 30, 2025 | -17.4 million | 2.5 million |
RZLT Net Income
No data available :(
RZLT Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 107.8 million | - | 276000 |
| March 31, 2026 | 120.3 million | - | 438000 |
| Dec. 31, 2025 | 132.9 million | - | 1.3 million |
| Sept. 30, 2025 | 152.2 million | - | 1.5 million |
RZLT Shares Outstanding
RZLT Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | - | 14.9 million | 6.7 million | - |
| March 31, 2026 | - | 11.4 million | 5.9 million | - |
| Dec. 31, 2025 | - | 14.3 million | 9.9 million | - |
| Sept. 30, 2025 | - | 13.1 million | 6.8 million | 167000 |
RZLT Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | - | 8000 |
| March 31, 2026 | - | 8000 |
| Dec. 31, 2025 | - | 7000 |
| Sept. 30, 2025 | - | 8000 |
RZLT
Price: $3.58
52 week price:
Earnings Per Share: -0.80 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 23600
Market Capitalization: 421.8 million